Section Arrow
LNTH.NASDAQ
- Lantheus Holdings
Quotes are at least 15-min delayed:2025/09/14 14:17 EDT
Regular Hours
Last
 52.94
-2.05 (-3.73%)
Day High 
54.72 
Prev. Close
54.99 
1-M High
60.135 
Volume 
842.60K 
Bid
52.45
Ask
54.23
Day Low
52.6 
Open
54.72 
1-M Low
51.4 
Market Cap 
3.74B 
Currency USD 
P/E 14.62 
%Yield -- 
10-SMA 54.56 
20-SMA 55.38 
50-SMA 65.03 
52-W High 118.21 
52-W Low 47.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.76/6.07
Enterprise Value
4.36B
Balance Sheet
Book Value Per Share
17.16
Cash Flow
Cash Flow Yield
0.13
Income Statement
Total Revenue
1.53B
Operating Revenue Per Share
17.73
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.12+0.06+5.66%-- 
IXHLIncannex Healthcare0.5475+0.0175+3.30%-- 
CGCCanopy Growth Corp1.37-0.02-1.44%-- 
VTRSViatris9.96-0.21-2.06%227.2PE
TEVATeva Pharmaceutical Industries Limited19.93+0.04+0.20%-- 
Quotes are at least 15-min delayed:2025/09/14 14:17 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.